Open original FDA record ↗Recall record
- FDA identifier
- Z-0529-2019
- Company in FDA record
- Helena Laboratories, Inc.
- FDA record creation date
- Nov 30, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Due to a customer experiencing complaints on bone fraction of assay not being in range. The complaint: ~12% lower enzyme activity was noted.
Source facts
- Action
- On 11/02/2016, the firm, Helena Laboratories, Inc., sent a "Withdrawal Notification" to customers via email. The notice described the product, problem and actions to be taken. The customers were instructed remove lot from inventory and discard; contact technical services at 1-800-231-5663 ext.1600 for MRA#; and complete Withdrawal Notification form and return copy to Helena Laboratories via FAX at:409-842-1874 or email to: jjones@helena.com. The firm is doing a Withdrawal of this lot, and will replace this material, if they have not already done so, with a new kit lot. If the customer indicates how many kits it has remaining, the firm will forward replacement, under Material Return Authorization and to use an enclosed form to report replacement needs. Customers are informed to contact Technical Services is 1-800-231-5663, Ext. 1600; for MRA#, and for questions, to contact Jessica Jones at extension 1177, or email jjones@helena.com. The firm's public contact may be reached at (409)842-3714 extension 1177.
- Initiated
- 2016-11-07
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2021-01-15
- Distribution
- Worldwide Distribution: US (nationwide) to states of: GA, IN, and MI, and countries of: Australia, Brazil, Canada, Japan and Hong Kong.
- Recall number
- Z-0529-2019
- Recall status
- Terminated
- CDRH record ID
- 168172
- FDA record created
- 2018-11-30
- Recall event number
- 81303